Acta diabetologica · 2025
Diabetic retinopathy screening telemedicine-based compared with standard of care : an economic analysis in a pilot experience of Italian healthcare.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Piatti Alberto, Borghese R, Perino G, Bellelli S, Rivoiro C, Tassone F, Romeo F, Doglio M, Ioli G Messori, Giorda G B
Аннотация
PURPOSE: This study aimed to provide an economic analysis of the Local Health Authority Turin 5 (ASL TO 5) teleophthalmology diabetic retinopathy screening program.
METHODS: A retrospective chart analysis was performed on the diabetologists' digital folder to compare the costs of ASL TO5 screening program to the Italian standard of care based on in-office examination by ophthalmologist . The total cost was calculated for the two methods of screening. Mean annual unadjusted cost data per patient have been calculated by type of cost component.
RESULTS: The study included 3,635 patients with diabetes mellitus screened for diabetic retinopathy (DR) in 2023-24. The total (direct and indirect) cost for teleophthalmology screening program was € 48,976 while the estimated cost for the same quantity of patients screened with traditional examination by ophthalmologist would have been € 148,486. The mean cost per patient of telescreening was € 13.5 ± 5.3 . Conversely traditional screening would have a mean cost € 40.9 ± 28 per patient (p-value < 0.001).
DISCUSSION: Advances in telemedicine are enhancing the DR screening strategies. Telescreening showed cost-savings of approximately € 100,000 for the Local Health Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation Authority ASL TO5 over a period of 2 years and for a screened population of 3,635. Telemedicine-based screening emerges as a less costly solution for the Italian National Health Service and can improve accessibility and compliance to this procedure.
CONCLUSIONS: This study provides an economic analysis of teleophthalmology DR screening program and highlights significant implications for patients, healthcare professionals and policymakers.
METHODS: A retrospective chart analysis was performed on the diabetologists' digital folder to compare the costs of ASL TO5 screening program to the Italian standard of care based on in-office examination by ophthalmologist . The total cost was calculated for the two methods of screening. Mean annual unadjusted cost data per patient have been calculated by type of cost component.
RESULTS: The study included 3,635 patients with diabetes mellitus screened for diabetic retinopathy (DR) in 2023-24. The total (direct and indirect) cost for teleophthalmology screening program was € 48,976 while the estimated cost for the same quantity of patients screened with traditional examination by ophthalmologist would have been € 148,486. The mean cost per patient of telescreening was € 13.5 ± 5.3 . Conversely traditional screening would have a mean cost € 40.9 ± 28 per patient (p-value < 0.001).
DISCUSSION: Advances in telemedicine are enhancing the DR screening strategies. Telescreening showed cost-savings of approximately € 100,000 for the Local Health Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation Authority ASL TO5 over a period of 2 years and for a screened population of 3,635. Telemedicine-based screening emerges as a less costly solution for the Italian National Health Service and can improve accessibility and compliance to this procedure.
CONCLUSIONS: This study provides an economic analysis of teleophthalmology DR screening program and highlights significant implications for patients, healthcare professionals and policymakers.